1. The Potential Role of CD44 and CD133 in Colorectal Stem Cell Cancer
   Wael Abdou Hassan et al, 2022, Cureus CrossRef
2. Metabolic vulnerability of cancer stem cells and their niche
   Laura Marrone et al, 2024, Frontiers in Pharmacology CrossRef
3. EpEX, the soluble extracellular domain of EpCAM, resists cetuximab treatment of EGFR-high head and neck squamous cell carcinoma
   Koki Umemori et al, 2023, Oral Oncology CrossRef
4. Inhibition of mitochondrial function by approved drugs overcomes nasopharyngeal carcinoma chemoresistance
   Yunlong Zhang et al, 2024, Anti-Cancer Drugs CrossRef
5. The Role of Altered Mitochondrial Metabolism in Thyroid Cancer Development and Mitochondria-Targeted Thyroid Cancer Treatment
   Siarhei A. Dabravolski et al, 2021, International Journal of Molecular Sciences CrossRef
6. Targeting cancer stem cells with antibiotics inducing mitochondrial dysfunction as an alternative anticancer therapy
   Igor Karp et al, 2022, Biochemical Pharmacology CrossRef
7. Gel-Free 3D Tumoroids with Stem Cell Properties Modeling Drug Resistance to Cisplatin and Imatinib in Metastatic Colorectal Cancer
   Chiharu Sogawa et al, 2021, Cells CrossRef
8. TRRAP Enhances Cancer Stem Cell Characteristics by Regulating NANOG Protein Stability in Colon Cancer Cells
   Kyung-Taek Kang et al, 2023, International Journal of Molecular Sciences CrossRef
9. Nanomaterials in tumor immunotherapy: new strategies and challenges
   Xudong Zhu et al, 2023, Molecular Cancer CrossRef
10. Drug repurposing of mito-atovaquone for cancer treatment
    Nemesio Villa-Ruano et al, 2023, Pharmaceutical Patent Analyst CrossRef
11. Inhibition of Wnt Signaling by Atovaquone Inhibits Gastric Cancer and Enhances Chemotherapy Effectiveness Through Activation of Casein Kinase 1α
    Rui Shang et al, 2024, Nutrition and Cancer CrossRef